Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo-Reference-Cited by-同舟云学术

Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo

Published:2019-08-22 Issue:1 Volume:19 Page:
ISSN:1471-2458
Container-title:BMC Public Health
language:en
Short-container-title:BMC Public Health

Author:

Keating Patrick,Carrion Martin Antonio Isidro^ORCID,Blake Alexandre,Lechevalier Pauline,Uzzeni Florent,Gignoux Etienne,Okonta Chibuzo,Langendorf Céline,Smit Sheilagh,Ahuka Steve,Suchard Melinda,Pukuta Elizabeth,Degail Marie-Amélie,Hansen Lisa,Kibanza-Kyungu Jerry,Ciglenecki Iza,Cohuet Sandra

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1186/s12889-019-7500-z.pdf

Reference26 articles.

1. Bland J, Clements J. Protecting the world’s children: the story of WHO’s immunization programme. World Health Forum. 1998;19(2):162–73.

2. Moss WJ. Measles. Lancet. 2017;390(10111):2490–502.

3. WHO/UNICEF. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. 2001.

4. WHO/UNICEF. WHO/UNICEF estimates of national immunization coverage. Geneva: World Health Organisation; 2010.

5. Dabbagh A, Laws RL, Steulet C, Dumolard L, Gacic-Dobo M, Mulders N, et al. Progress towards regional measles elimination – worldwide, 2000–2017. Wkly Epidemiol Rec. 2018;48:12.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of measles IgG enzyme immunoassays (EIA) versus plaque reduction neutralization test (PRNT) for measuring measles serostatus: a systematic review of head-to-head analyses of measles IgG EIA and PRNT;BMC Infectious Diseases;2023-05-31

2. Use of a rapid digital microfluidics-powered immunoassay for assessing measles and rubella infection and immunity in outbreak settings in the Democratic Republic of the Congo;PLOS ONE;2022-12-21

3. Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response;Vaccine;2021-09

4. Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response;2021-05-21

5. Measles: the long walk to elimination drawn out by COVID-19;The Lancet Global Health;2021-03